Pharmaceuticals Best Practices
Best Practices, LLC has conducted extensive research in the field of Pharmaceuticals. Browse through and sample our published Pharmaceuticals research in the topics below:
| |  | CRO Bioequivalence Strategies: Performance Metrics, Processes & Trends
Pharmaceutical companies are on a constant lookout to improve efficiency and reduce costs when conducting bioequivalence studies. Thus, they increasingly use contract research organizations (CROs) to conduct these critical studies. This not only helps to reduce costs, but it also has been proved to produce efficient clinical trial results. Also, CROs are often challenged with competitive prices and are constantly looking at further enhancing the quality of their testing programs.
Best Practices, LLC conducted the research that led to this report to provide benchmarking data that CROs can use to evaluate the performance of their bioequivalence testing programs. Specifically, this research study aims to identify key cost, quality and productivity metrics for the process of conducting bioequivalence studies required to bring a new generic drug to market. In addition to metrics, the study includes management insights, lessons learned and best practices for productivity in the bioequivalence study process.
Pharma Bioequivalence Strategies: Performance Metrics, Processes & Trends
Generic pharmaceutical manufacturing companies are expected to increase outsourcing for bioequivalence studies to less regulated countries in the near future. However, selecting a contact research organization (CRO) that is cost efficient and at the same time provides quality results is often challenging. In addition, companies have to make sure that CROs are adhering to protocols and correct guidelines when conducting bioequivalence studies.
Best Practices, LLC conducted this timely benchmarking research that identifies key cost, quality and productivity metrics for the process of conducting bioequivalence studies required to bring a new generic drug to market. Specifically, this study looks at the growing trend in outsourcing for bioequivalence studies. In addition, the study also includes executive insights, lessons learned and best practices for productivity in the bioequivalence study process. Generic companies can use the comparative metrics in this study to evaluate their current bioequivalence testing programs.
|
|